Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2338 (LINC02338)

Target
LINC02338
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2338 (LINC02338) is a member of the long intergenic non-coding RNAs (lincRNAs), a subclass of long non-coding RNAs defined as transcripts longer than 200 nucleotides that do not encode proteins and are transcribed from genomic regions between protein-coding genes. LincRNAs can act as regulators of gene expression at transcriptional, post-transcriptional, and epigenetic levels and may function locally or at a distance through interactions with DNA, RNA, or proteins. While some lincRNAs are recognized for their roles in disease and gene regulation, most—including LINC02338—remain poorly characterized, with no established function, disease association, or therapeutic targeting evidence currently in the literature. LINC02338 is annotated in databases such as NCBI Gene and Ensembl. There are no reported small molecules, biologics, or other drugs that directly target this lincRNA, nor is it currently considered a classical therapeutic target such as a receptor, enzyme, or transporter. Its potential clinical utility or pathogenic roles remain to be established.

Other names
LINC02338long intergenic non-protein coding RNA 2338
02

Mechanism of action

Not applicable; no drugs are known to interact with LINC02338

03

Biological functions

Potential roles in gene regulation (transcriptional and epigenetic regulation, both in cis and trans, seen for lincRNAs in general)Scaffolding for chromatin-modifying complexesPossible involvement in cell cycle regulation or cell size
04

Disease associations

Some lincRNAs are implicated in cancer (as oncogenes or tumor suppressors)
05

Safety considerations

None reportedGeneral issues with lincRNAs as therapeutic targets: lack of conservation, uncertain function, difficult druggability
06

Biomarkers

Some lincRNAs serve as diagnostic biomarkers in diseases like cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2338 (LINC02338).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2338 (LINC02338).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call